A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice

NCT01460745 · clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators